Mixed-effects regression models for studying the natural history of prostate disease.
暂无分享,去创建一个
H. Carter | C. Morrell | J. Pearson | L. Brant | H B Carter | P. Landis | L J Brant | J D Pearson | C H Morrell | P K Landis
[1] A. Rademaker,et al. Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. , 1990, The Journal of urology.
[2] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[3] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[4] W. Catalona,et al. Clinical use of prostate specific antigen in patients with prostate cancer. , 1989, The Journal of urology.
[5] W. Cooner,et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. , 1990, The Journal of urology.
[6] I. Rossman,et al. Normal Human Aging: The Baltimore Longitudinal Study of Aging , 1986 .
[7] T. Stamey,et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. , 1988, The New England journal of medicine.
[8] D. Bates,et al. Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data , 1988 .
[9] P. Walsh,et al. The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.
[10] J. Oesterling,et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. , 1988, The Journal of urology.
[11] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. , 1989, The Journal of urology.
[12] David W. Bacon,et al. Estimating the transition between two intersecting straight lines , 1971 .
[13] E. Metter,et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.
[14] T. Stamey,et al. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. , 1989, The Journal of urology.
[15] D. S. Coffey,et al. The prostate: An increasing medical problem , 1990, The Prostate.
[16] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[17] K Y Liang,et al. An overview of methods for the analysis of longitudinal data. , 1992, Statistics in medicine.
[18] D. Chan,et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. , 1992, Cancer research.
[19] J. Oesterling,et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. , 1990, The Journal of urology.